S&P 500
(-0.14%) 5 461.45 points
Dow Jones
(-0.11%) 39 069 points
Nasdaq
(0.13%) 17 740 points
Oil
(-0.12%) $80.73
Gas
(-3.34%) $2.66
Gold
(-0.75%) $2 313.40
Silver
(0.15%) $28.91
Platinum
(1.87%) $1 004.80
USD/EUR
(0.32%) $0.936
USD/NOK
(0.72%) $10.68
USD/GBP
(0.49%) $0.792
USD/RUB
(0.29%) $87.75

के लिए वास्तविक समय के अद्यतन Arbutus Biopharma Corp [ABUS]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Biotechnology
अंतिम अद्यतन26 Jun 2024 @ 20:54

-2.46% $ 2.98

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:54):
Our systems believe the stock currently is undervalued by 2.07% compare to its pairs and should correct upwards.

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States...

Stats
आज की मात्रा 271 211
औसत मात्रा 1.31M
बाजार मूल्य 561.43M
EPS $-0.100 ( Q1 | 2024-05-02 )
अगली कमाई की तारीख ( $-0.100 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -6.76
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00300 (0.10%)
AADI -2.65%
ABCL 1.79%
ABCM 0.04%
ABEO -2.84%
ABIO -0.98%
ABOS 0.70%
ABSI 2.89%
ABUS -2.46%
ABVX -3.53%
ACAD -0.83%
ACER -17.95%
ACET -3.40%
ACGN 1.29%
ACHL -4.15%
ACHV -1.72%
ACIU -0.50%
ACLX -0.13%
ACRV -4.79%
ACST -1.63%
ACXP 0.65%
ADAG 4.64%
ADAP -2.80%
ADGI 0.87%
ADIL 0.54%
ADMA -2.41%
ADPT -0.44%
ADTX -3.47%
ADVM -3.18%
ADXN -1.60%
AEON -3.74%
AEZS -3.51%
AFMD -1.40%
AGEN -1.61%
AGIO -1.88%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -3.13%
AKRO -2.70%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.11%
ALEC -3.90%
ALGS -2.41%
ALKS -0.21%
ALLK -8.90%
ALLO -6.64%
ALLR -4.09%
ALNA 3.16%
ALNY 1.62%
ALPN 0.02%
ALPX 0.00%
ALRN -1.67%
ALT -9.46%
ALVR -0.59%
ALXN 0.00%
ALXO -10.65%
ALZN 4.78%
AMRN 0.26%
AMTI -3.13%
ANAB 0.42%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.44%
ANPC -3.15%
APGE -0.96%
APGN 8.48%
APGNW 30.65%
APLM 1.56%
APLS 0.22%
APLT -3.94%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 4.70%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -4.03%
ARDS -14.23%
ARDX -0.91%
ARGX -0.93%
ARNA 0.00%
ARPO -0.90%
ARQT -0.52%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.19%
ARWR -1.77%
ASLN -3.44%
ASMB -3.77%
ASND -0.91%
ATAI -1.48%
ATHA 5.94%
ATHE 1.12%
ATHX -33.50%
ATNF 0.98%
ATOS 3.86%
ATRA -2.89%
ATXI 1.93%
ATXS -0.89%
AUPH -0.99%
AURA -0.15%
AUTL -1.87%
AVBP -2.79%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -5.52%
AVTX -1.25%
AVXL -2.84%
AXLA 0.00%
AXSM -1.73%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.52%
BCAB 3.92%
BCDA -2.07%
BCDAW -41.77%
BCEL 0.00%
BCLI 2.60%
BCRX 1.56%
BCTX 8.12%
BCTXW -21.88%
BCYC 0.55%
BDRX -5.90%
BDTX -0.85%
BEAM 0.08%
BFRA -2.91%
BGNE -2.19%
BIOR -3.40%
BIVI 0.56%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.85%
BLTE -0.62%
BLU 0.03%
BLUE -0.81%
BMEA -9.77%
BMRN 0.34%
BNOX -2.22%
BNTC -2.11%
BNTX -1.21%
BOLD -8.15%
BOLT -0.18%
BPMC -1.22%
BPTH 1.86%
BPTS -13.47%
BRNS -0.74%
BRTX -2.38%
BTAI 24.58%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.33%
CABA 0.90%
CADL -1.23%
CALA 0.00%
CALC -1.77%
CALT -0.59%
CAPR -3.01%
CARA -0.62%
CARM 12.13%
CASI -1.67%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -7.00%
CCCC -5.26%
CCXI 0.00%
CDAK 0.00%
CDIO -3.09%
CDIOW 24.00%
CDMO -2.82%
CDMOP 0.04%
CDT -10.57%
CDTTW -39.60%
CDTX -1.92%
CDXC -0.41%
CDXS 4.31%
CELC -3.82%
CELU -1.50%
CELUW 11.80%
CERC -1.68%
CERE -0.78%
CERO -3.60%
CEROW -10.18%
CFRX -27.95%
CGEM -2.74%
CGEN -3.31%
CGON -0.13%
CGTX -4.55%
CHMA -6.00%
CHRS -0.63%
CINC 0.00%
CING 0.70%
CINGW 34.95%
CKPT -2.89%
CLBS -16.75%
CLDX -2.32%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.41%
CLSD -2.90%
CLSN -0.68%
CLVS 0.00%
CMMB -0.01%
CMND 3.63%
CMPI 0.00%
CMPX -8.23%
CMRA 0.00%
CMRAW 33.33%
CMRX -2.71%
CNCE 0.00%
CNSP -41.20%
CNST 0.00%
CNTA -0.73%
CNTB -2.25%
CNTX -6.85%
COCP -2.02%
COEPW 32.45%
COGT -3.00%
CORT 2.30%
COYA -1.46%
CPRX -0.79%
CRBP -1.85%
CRBU -4.84%
CRDF -2.21%
CRGX 1.27%
CRIS -0.38%
CRNX -6.21%
CRSP 0.99%
CRTX 2.63%
CRVO -2.50%
CRVS 1.12%
CSBR -1.59%
CTCX -1.63%
CTIC 0.06%
CTMX -2.50%
CTNM -2.13%
CTXR 1.13%
CUE 3.53%
CVAC -1.98%
CVKD 0.15%
CWBR 2.80%
CYAD -12.96%
CYCC 9.84%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -2.04%
CYTO -2.73%
DARE 6.54%
DAWN 0.30%
DBTX -0.81%
DBVT -2.08%
DFFN 10.28%
DICE 0.06%
DMAC 32.60%
DNLI -1.97%
DNTH -6.01%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.51%
DTIL 0.89%
DYAI 9.68%
EARS -1.77%
EDIT -2.51%
EDSA -1.00%
EFTR 7.18%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -5.19%
ELOX 7.69%
ELTX -0.88%
ELVN -4.52%
ELYM 0.77%
ENGN 1.67%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 5.11%
ENTA -0.49%
ENTO -0.07%
ENTX 0.69%
ENVB 1.10%
EPIX -0.10%
EPRX -2.97%
EPZM 0.00%
EQ 0.86%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.44%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -0.51%
ETON -0.30%
ETTX 0.00%
EVAX -2.14%
EVGN 6.35%
EVLO 0.00%
EWTX -0.03%
EXAI -0.76%
EXEL -0.27%
EYEG -0.69%
EYEN 1.54%
EYPT 0.00%
FATE -8.06%
FBIO 0.59%
FBIOP 0.92%
FBLG -17.00%
FBRX -0.04%
FDMT -4.59%
FENC -1.29%
FGEN -4.70%
FHTX 1.43%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.53%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.53%
FULC -3.51%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.73%
GANX -1.42%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -3.65%
GHRS -2.85%
GLMD -2.15%
GLPG -2.30%
GLSI 2.80%
GLTO -1.20%
GLUE -1.58%
GLYC -9.59%
GMAB -0.47%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.52%
GNLX 1.56%
GNPX 0.98%
GNTA 3.94%
GOSS -7.81%
GOVX 4.50%
GOVXW -49.04%
GPCR -6.86%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 0.14%
GRTX 0.00%
GTHX 0.02%
GUTS -4.85%
GXGXW 41.67%
GYRE -6.02%
HALO -0.77%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -1.91%
HOOK 1.13%
HOTH -2.70%
HOWL -2.14%
HRMY 1.10%
HRTX 1.97%
HSTO 0.00%
HUMA 1.12%
HUMAW -0.01%
IBRX -4.13%
ICCC 0.22%
ICPT 0.21%
ICU 16.67%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.50%
IFRX -2.66%
IGMS -0.11%
IKNA 0.60%
IKT 1.42%
IMAB -0.58%
IMCR -2.60%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -7.76%
IMNM -1.65%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX -0.84%
IMTX -1.58%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.62%
INAB 0.59%
INBX 0.46%
INCY -0.89%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -2.20%
INMB 2.65%
INO -1.82%
INSM -0.77%
INTS -2.75%
INVA 0.22%
INZY 0.92%
IOBT -11.02%
IONS 0.06%
IOVA -2.31%
IPA 2.46%
IPHA 5.58%
IPSC -1.95%
IRON -2.35%
ISEE 0.38%
ITOS -1.57%
ITRM 1.67%
IVA 6.96%
IVVD -3.72%
JAGX 1.04%
JANX -4.26%
JAZZ -0.54%
JNCE 0.00%
JSPR -6.20%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.94%
KALV -2.16%
KDNY 0.22%
KMPH -0.34%
KNSA -2.95%
KNTE -0.38%
KOD -6.72%
KPRX 0.96%
KPTI -1.83%
KRBP -10.00%
KRON 1.05%
KROS -1.18%
KRRO -6.34%
KRTX 0.03%
KRYS -0.89%
KTRA 17.17%
KTTA 8.16%
KTTAW 0.92%
KURA -1.81%
KYMR -2.26%
KYTX -3.49%
KZIA 5.16%
KZR -1.49%
LABP 0.57%
LBPH -0.89%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.65%
LENZ -4.07%
LEXX 0.00%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -8.51%
LIAN -8.28%
LIFE 2.70%
LIPO -7.10%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 0.70%
LPCN -5.03%
LPTX -1.65%
LQDA -0.24%
LRMR -1.92%
LSTA -4.06%
LTRN 0.25%
LUMO -1.32%
LVTX 0.00%
LXEO -4.83%
LXRX -2.06%
LYEL -35.47%
LYRA 2.71%
MACK 0.10%
MBIO -9.02%
MBRX -1.72%
MCRB 1.36%
MDGL -2.64%
MDNA -13.16%
MDWD 0.10%
MDXG -2.58%
MEIP -0.13%
MESO -1.78%
MGNX -3.03%
MGTA -7.74%
MGTX -2.61%
MGX -2.68%
MIRM -1.42%
MIRO 0.59%
MIST 1.54%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.63%
MLYS -6.11%
MNKD -0.95%
MNMD 0.28%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.06%
MORF -3.70%
MREO -4.14%
MRKR 2.68%
MRNA -4.95%
MRNS -4.03%
MRSN -2.62%
MRTX -0.17%
MRUS 0.26%
MRVI -1.97%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.08%
MYMD 8.38%
NAMS 1.37%
NAMSW 0.43%
NAUT 1.14%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.09%
NERV -1.87%
NEXI 2.60%
NGM -1.28%
NGNE -1.40%
NKGN 5.88%
NKGNW 8.00%
NKTR -3.27%
NKTX -4.57%
NLSP -2.77%
NLSPW 26.67%
NMRA -0.74%
NMTR -42.97%
NOVN -24.84%
NRBO 12.16%
NRIX -0.63%
NRSN -3.63%
NRSNW 0.00%
NRXP -5.39%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -6.17%
NTRBW -31.07%
NUVL -2.15%
NVAX -1.57%
NVCT 3.58%
NVIV -34.28%
NXTC -2.95%
NYMX -0.05%
OABI 0.40%
OABIW -10.06%
OBIO -3.21%
OBSV 0.00%
OCEA 0.00%
OCGN 4.26%
OCS -1.02%
OCUL -1.83%
OCUP 1.97%
ODT -4.27%
OKYO 1.51%
OLMA -5.63%
OMER -0.90%
OMGA 6.25%
ONCO 7.71%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 1.03%
ORGS -4.53%
ORIC -3.42%
ORMP 15.18%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.43%
OYST 0.00%
PALI -0.87%
PASG -1.31%
PBLA -7.50%
PBM -8.30%
PBYI 1.69%
PCSA 0.00%
PCVX -0.23%
PDSB -0.80%
PEPG 1.70%
PGEN -3.59%
PHAR 1.51%
PHAS 0.00%
PHAT -1.26%
PHIO -3.62%
PHIOW 36.47%
PHVS -7.22%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -0.73%
PLUR 6.01%
PMN 0.72%
PMVP -1.19%
PNT 0.16%
PPBT 0.28%
PRAX 0.63%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK 0.89%
PRQR -0.01%
PRTA -2.34%
PRTC 0.49%
PRTG -0.50%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -5.11%
PSTX -1.17%
PTCT -0.16%
PTE -0.82%
PTGX -1.64%
PTIXW -49.04%
PULM 2.62%
PXMD 0.00%
PYPD 0.07%
PYXS 3.59%
QLGN -3.72%
QNCX 5.70%
QNRX 0.37%
QSI -11.93%
QSIAW -3.13%
QTTB -4.54%
QURE -0.22%
RAIN -1.63%
RANI 6.42%
RAPT -3.22%
RARE 1.22%
RCKT -8.08%
REGN -0.74%
RENB -3.42%
REPL -3.00%
RETA 0.02%
REUN -0.89%
REVB -1.42%
REVBU 3.46%
REVBW 4.38%
RGLS -4.91%
RGNX -5.19%
RIGL -3.29%
RLAY -4.60%
RLMD 0.33%
RLYB -0.34%
RNA -0.36%
RNAC -5.65%
RNAZ -0.95%
RNXT 1.88%
ROIV -2.08%
ROIVW 4.56%
RPHM -0.31%
RPRX 0.30%
RPTX -2.05%
RUBY 2.70%
RVLP -32.05%
RVMD -1.15%
RVMDW -30.00%
RVNC 1.70%
RVPH -1.02%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.41%
RYTM -6.25%
RYZB 0.02%
RZLT 1.29%
SABS -1.37%
SABSW -11.81%
SAGE 1.56%
SANA -4.24%
SAVA -0.26%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH -0.25%
SCPS 0.00%
SEEL -4.09%
SEER -0.44%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.01%
SGMT -1.69%
SGTX -2.56%
SIOX 22.63%
SLDB -4.73%
SLGL 4.00%
SLN -4.21%
SLNO -2.82%
SLRX 5.91%
SLS -2.99%
SMMT -2.62%
SNDX 0.72%
SNGX -3.02%
SNPX -0.81%
SONN -1.08%
SPPI -0.49%
SPRB 0.30%
SPRC -4.17%
SPRO 0.04%
SRNE -34.00%
SRPT -1.16%
SRRA 0.00%
SRRK -2.35%
SRZN -2.45%
STAB 0.00%
STOK -4.88%
STRO -2.68%
STSA 0.00%
STTK -4.78%
SURF -0.93%
SVRA -2.89%
SWTX 0.33%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -8.06%
TARS 0.08%
TBPH 0.48%
TCBP 2.74%
TCDA 0.00%
TCON -2.43%
TCRR 0.00%
TCRT 1.59%
TCRX 2.67%
TECH -0.07%
TENX -1.27%
TERN -6.62%
TFFP -3.05%
TGTX -2.87%
THRX 0.12%
TIL -0.20%
TLC 0.00%
TLSA -4.13%
TNGX -2.27%
TNXP -5.59%
TNYA -8.93%
TPST 2.42%
TRDA -3.86%
TRVI 1.15%
TRVN 5.02%
TSHA -23.94%
TSVT -3.06%
TTNP -9.27%
TVTX 0.63%
TYRA -8.19%
UBX -2.12%
UNCY -3.40%
URGN -1.94%
UTHR -0.28%
VACC 11.36%
VALN -2.89%
VAXX 87.50%
VBIV 0.78%
VBLT -8.77%
VCEL 0.29%
VCNX 10.35%
VCYT -1.23%
VERA -2.80%
VERU 0.73%
VERV -2.58%
VIGL 5.11%
VINC 1.62%
VIR 0.65%
VIRI -1.61%
VIRX 2.38%
VKTX -1.05%
VLON -13.04%
VNDA -2.36%
VOR -2.41%
VRCA 0.28%
VRDN -4.00%
VRNA -1.20%
VRPX 0.38%
VRTX 0.10%
VSTM -3.40%
VTGN -0.46%
VTVT -2.97%
VTYX -0.21%
VXRT -2.26%
VYGR -1.66%
VYNE -3.47%
VYNT 7.78%
WINT -3.24%
WVE -4.40%
XBIO 0.93%
XBIT 1.46%
XCUR 3.61%
XENE -3.11%
XERS 2.38%
XFOR 3.11%
XLO 4.43%
XLRN 0.00%
XNCR 0.05%
XOMA -3.14%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.92%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.24%
ZNTL -2.98%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-05-23 Burgess Daniel D Buy 67 000 Stock Option (Right to Buy)
2024-05-23 Manchester Keith S Buy 67 000 Stock Option (Right to Buy)
2024-05-23 Henriques Richard C Jr Buy 67 000 Stock Option (Right to Buy)
2024-05-23 Meyers James R Buy 67 000 Stock Option (Right to Buy)
2024-05-23 Rewolinski Melissa Buy 67 000 Stock Option (Right to Buy)
INSIDER POWER
91.25
Last 96 transactions
Buy: 35 936 262 | Sell: 1 766 657
सहसंबंध (AI algo v.1.1b): Undervalued: 2.07% $3.04 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.41 (neutral)
छोटा: 0.39 (neutral)
Signal:(65.754) Neutral

Arbutus Biopharma Corp सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
AGBAW0.914
MTTR0.914
DECAU0.894
IBTA0.884
ANL0.863
NNAVW0.851
ICCH0.851
CALC0.848
DHAI0.844
MOBX0.832
10 सबसे अधिक नकारात्मक सहसंबंध
OZEM-1
BKHA-0.909
OCTO-0.903
HTZWW-0.894
INTJ-0.881
QRMI-0.88
SCLX-0.876
CDIO-0.87
CTCX-0.856
SERV-0.853

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Arbutus Biopharma Corp सहसंबंध - मुद्रा/वस्त्र

The country flag -0.60
( weak negative )
The country flag -0.32
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.44
( neutral )
The country flag 0.11
( neutral )

Arbutus Biopharma Corp वित्तीय

Annual 2023
राजस्व: $18.14M
सकल लाभ: $16.74M (92.26 %)
EPS: $-0.440
FY 2023
राजस्व: $18.14M
सकल लाभ: $16.74M (92.26 %)
EPS: $-0.440
FY 2022
राजस्व: $39.02M
सकल लाभ: $37.59M (96.34 %)
EPS: $-0.460
FY 2021
राजस्व: $10.99M
सकल लाभ: $0.00 (0.00 %)
EPS: $-0.830

Financial Reports:

No articles found.

Arbutus Biopharma Corp Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Arbutus Biopharma Corp

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company's research and development programs include AB-161, an oral HBV RNA destabilizer to destabilize HBV RNA, which leads in the reduction of HBsAg and other viral proteins; AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune response; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has strategic alliance, licensing, and research collaboration agreements with Talon Therapeutics, Inc.; Gritstone Oncology, Inc.; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd.; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Vaccitech plc to evaluate a triple combination of AB-729 for the treatment of chronic HBV infection. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 1.7524399757385 seconds
Number of API calls: 3
Number of DB calls: 9